• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about AWKNF

    Recent news which mentions AWKNF

    < Previous 1 2 3 Next >
    Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
    Tickers AWKNF NEWS
    Tags Cannabis Market News Madeleine King
    From Benzinga
    Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
    Tickers AWKNF NEWS
    Tags News Press Releases Anthony Tennyson
    From Benzinga
    Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
    Tickers AWKNF BETRF CMND FLHLF
    Tags Psychedelics Reform MDXXF Psychedelics Research
    From Benzinga
    Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
    Tickers ATAI AWKNF CMND CYBN
    Tags MNMD Psychedelics Financing Benzinga
    From Benzinga
    Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
    Tickers AWKNF CMND CMPS FLHLF
    Tags MDXXF Management Financing
    From Benzinga
    Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
    Tickers ATAI AWKNF CMND CMPS
    Tags Market News Markets CMND
    From Benzinga
    Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation
    Tickers AWKNF
    Tags AWKNF Psychedelics Penny Stocks
    From Benzinga
    Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
    Tickers ATAI AWKNF CMPS CYBN
    Tags Psychedelics Financing MNMD HUGE
    From Benzinga
    UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
    Tickers AWKNF CMPS
    Tags Markets Cannabis severe alcohol use disorder
    From Benzinga
    U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
    Tickers AWKNF
    Tags Psychedelics Benzinga AWKNF
    From Benzinga
    Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
    Tickers ATAI AWKNF CMND CMPS
    Tags CMPS CYBN IXHL
    From Benzinga
    Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial
    Tickers AWKNF
    Tags Markets Cannabis Market News
    From Benzinga
    Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
    Tickers AGNPF ATAI AWKNF CMPS
    Tags PLSH MNMD American Psychedelic Practitioners Association
    From Benzinga
    Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
    Tickers ATAI AWKNF CMPS CYBN
    Tags News ATAI GHRS
    From Benzinga
    Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
    Tickers AWKNF
    Tags Psychedelic/Assisted Therapies Ketamine Treatment Psychedelics
    From Benzinga
    Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder
    Tickers AWKNF
    Tags Market News Cannabis Markets
    From Benzinga
    Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
    Tickers AWKNF CMPS DMTTF FLHLF
    Tags Small Cap Psychedelics Reform PLSH
    From Benzinga
    Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
    Tickers AWKNF
    Tags Global Market News M&A
    From Benzinga
    Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
    Tickers AWKNF
    Tags Global Cannabis Market News
    From Benzinga
    Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism
    Tickers AWKNF
    Tags AWKNF Psychedelics Benzinga
    From Benzinga
    Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
    Tickers AWKNF IXHL MNMD MSSTF
    Tags REUN IXHL MNMD
    From Benzinga
    Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
    Tickers AWKNF
    Tags Psychedelics Benzinga AWKNF
    From Benzinga
    Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
    Tickers AWKNF CMND DRUG HUGE
    Tags PSIL Markets CMND
    From Benzinga
    Severe Alcohol Use Disorder Patients Will Try Ketamine Therapy At Awakn's New Phase 3 Study
    Tickers AWKNF
    Tags News Top Stories Penny Stocks
    From Benzinga
    EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
    Tickers AWKNF
    Tags Psychedelics MDMA/assisted therapy FDA
    From Benzinga
    Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
    Tickers ATAI AWKNF CYBN FLHLF
    Tags Psychedelics Financing MNMD AWKNF
    From Benzinga
    Awakn's Psychedelics Medical Chief Steps Down, Shifts In Company's Stocks And Ownership
    Tickers AWKNF
    Tags Psychedelics Financing News AWKNF
    From Benzinga
    EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
    Tickers AWKNF
    Tags Market News Cannabis Markets
    From Benzinga
    Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
    Tickers ATAI AWKNF CYBN DMTTF
    Tags Penny Stocks Benzinga Psychedelics Capital Conference ATAI
    From Benzinga
    Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
    Tickers AGNPF AWKNF BRAXF CMPS
    Tags Prince Harry Psychedelics CMPS
    From Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.